Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease
AbstractObjective Proton pump inhibitor (PPI) use has been associated with reduced diversity of the gut microbiome and may lead to worse clinical outcomes in inflammatory bowel disease (IBD). We aimed to evaluate whether PPI use affects clinical outcomes in a real-world setting.Design Healthcare cla...
Main Authors: | Tenzin Choden, Hui Zhang, Atsushi Sakuraba |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2023.2198775 |
Similar Items
-
Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019-08-01) -
Proton pump inhibitors overuse - consequences among patients
by: Patrycja Kmiotek, et al.
Published: (2019-08-01) -
Co-Administration of Proton Pump Inhibitors May Negatively Affect the Outcome in Inflammatory Bowel Disease Treated with Vedolizumab
by: Kata Szemes, et al.
Published: (2024-01-01) -
Do the benefits outweigh the risks? Potential dangers associated with long-term therapy of proton pump inhibitors
by: Wolanin Wolanin, et al.
Published: (2023-05-01) -
Strategies for discontinuation of proton pump inhibitors (PPIs) in patients with long-term PPI administration: a randomized controlled trial
by: Mariko Hojo, et al.
Published: (2022-01-01)